gag-vpu cross talk modulating hiv-1 envelope incorporation and infectivity in cell-type dependent...

1
POSTER PRESENTATION Open Access Gag-Vpu cross talk modulating HIV-1 envelope incorporation and infectivity in cell-type dependent manner Archana Gautam * , Ajit Patil, Jayanta Bhattacharya From First International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2012) Chennai, India. 20-22 January 2012 Introduction HIV-1 Vpu plays important role in enhancing virus release and CD4 down-modulation. We investigated the effect of Vpu-Gag cross talk on envelope incorporation and assembly in different cell types including primary cells. Methods We introduced Vpu start codon mutation and point substitution in p17 Gag matrix (L30E) in HIV-1 pNL- AD8 through PCR. Progeny viruses were produced in two cell-types: 293T and HeLa by transfection. Infectiv- ity potential of Vpu+/Vpu- viruses carrying Gag (L30E) mutation was assessed in TZM-bl cell line and their replication potential in peripheral blood mononuclear cells (PBMC) and monocyte-derived macrophages. The effect of mutation on virus release, envelope incorpora- tion and infectivity was determined by RT ELISA and Western blot. Results The amount of virus release from 293T and HeLa cells was similar in Vpu+/Vpu- constructs carrying Gag (L30E) mutation but the infectivity potential of viruses varied, showing enhanced infectivity of Vpu(-) Gag L30E viruses produced from 293T cell and HeLa cells. Envel- ope incorporation assay using 293T cells revealed that Vpu+ viruses with L30E mutation showed inefficient incorporation of HIV-1 envelope on cell-free virions whereas viruses with Vpu-/ L30E mutation resulted in efficient envelope incorporation and thereby increasing their infectivity potential. While similar results were obtained with PBMC and macrophages as found with 293T and HeLa cells, these effects were found to vary in different cell types. Conclusion HIV-1 envelope incorporation and infectivity is depen- dent on cross talk between p17 Gag, Vpu and Envelope and the effect of Gag p17 mutation on envelope is Vpu- mediated. Published: 4 May 2012 doi:10.1186/1471-2334-12-S1-P49 Cite this article as: Gautam et al.: Gag-Vpu cross talk modulating HIV-1 envelope incorporation and infectivity in cell-type dependent manner. BMC Infectious Diseases 2012 12(Suppl 1):P49. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit * Correspondence: [email protected] Department of Molecular Virology, National AIDS Research Institute, G-73, MIDC, Bhosari, Pune-411026, India Gautam et al. BMC Infectious Diseases 2012, 12(Suppl 1):P49 http://www.biomedcentral.com/1471-2334/12/S1/P49 © 2012 Gautam et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Upload: jayanta-bhattacharya

Post on 30-Sep-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

POSTER PRESENTATION Open Access

Gag-Vpu cross talk modulating HIV-1 envelopeincorporation and infectivity in cell-typedependent mannerArchana Gautam*, Ajit Patil, Jayanta Bhattacharya

From First International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2012)Chennai, India. 20-22 January 2012

IntroductionHIV-1 Vpu plays important role in enhancing virusrelease and CD4 down-modulation. We investigated theeffect of Vpu-Gag cross talk on envelope incorporationand assembly in different cell types including primarycells.

MethodsWe introduced Vpu start codon mutation and pointsubstitution in p17 Gag matrix (L30E) in HIV-1 pNL-AD8 through PCR. Progeny viruses were produced intwo cell-types: 293T and HeLa by transfection. Infectiv-ity potential of Vpu+/Vpu- viruses carrying Gag (L30E)mutation was assessed in TZM-bl cell line and theirreplication potential in peripheral blood mononuclearcells (PBMC) and monocyte-derived macrophages. Theeffect of mutation on virus release, envelope incorpora-tion and infectivity was determined by RT ELISA andWestern blot.

ResultsThe amount of virus release from 293T and HeLa cellswas similar in Vpu+/Vpu- constructs carrying Gag(L30E) mutation but the infectivity potential of virusesvaried, showing enhanced infectivity of Vpu(-) Gag L30Eviruses produced from 293T cell and HeLa cells. Envel-ope incorporation assay using 293T cells revealed thatVpu+ viruses with L30E mutation showed inefficientincorporation of HIV-1 envelope on cell-free virionswhereas viruses with Vpu-/ L30E mutation resulted inefficient envelope incorporation and thereby increasingtheir infectivity potential. While similar results were

obtained with PBMC and macrophages as found with293T and HeLa cells, these effects were found to vary indifferent cell types.

ConclusionHIV-1 envelope incorporation and infectivity is depen-dent on cross talk between p17 Gag, Vpu and Envelopeand the effect of Gag p17 mutation on envelope is Vpu-mediated.

Published: 4 May 2012

doi:10.1186/1471-2334-12-S1-P49Cite this article as: Gautam et al.: Gag-Vpu cross talk modulating HIV-1envelope incorporation and infectivity in cell-type dependent manner.BMC Infectious Diseases 2012 12(Suppl 1):P49.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

* Correspondence: [email protected] of Molecular Virology, National AIDS Research Institute, G-73,MIDC, Bhosari, Pune-411026, India

Gautam et al. BMC Infectious Diseases 2012, 12(Suppl 1):P49http://www.biomedcentral.com/1471-2334/12/S1/P49

© 2012 Gautam et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited.